Akkermansia muciniphila (AKK)
Akkermansia muciniphila (AKK) is a probiotic bacterium that naturally lives in the large intestine and protects and strengthens the intestinal lining. It makes up 3%-5% of the gut microbiota in healthy people and is essential for maintaining a healthy gut microbiome. Although AKK constitutes only 3%-5% of the gut microbiota, its abundance is negatively correlated with risks of inflammatory bowel disease (IBD), obesity, type 2 diabetes, and positively correlated with the efficacy of PD-1/PD-L1 inhibitors in cancer immunotherapy, earning it the titles of “Longevity bacterium” and “Lean bacterium”.
Benefits of Akkermansia muciniphila (AKK)
Gut microbes play an important role in the balance between health and disease. Akk is a type of intestinal microbe, and its ability to degrade intestinal mucin makes it a key organism at the interface between the intestinal lumen and the host cell mucosa.
AKK demonstrates potential therapeutic roles in diverse conditions such as diabetes, obesity, progeria, lateral sclerosis (ALS), inflammatory bowel disease (IBD), and hypertension, with particularly promising applications in metabolic regulation and immunotherapy. Many studies showed that AKK great benefit in weight loss, blood sugar control and intestine health with effective dose of 1 million cfu/day.
Currently, it is widely recognized as the most marketable and commercially valuable next-generation beneficial microbe.
Application
Health food
Medical food
Nutrition supplement
Why choose Coway
- Pure AKK with no contaminating bacteria.
- 100 billion CFU/g specification can be achieved, which is industry-leading commercial specifications
- 100-ton capacity enable us the stable in-house AKK supply chain.
- Both live and inactivated AKK can provide, and continuous optimization of production process enhance the highest activity and stability.
Specifications:
≥3.0◊1011 cfu/g (tfu/g)
We also provide OEM service for AKK finished product in capsule form and powder stick form.
